AZ Lab Life Sciences Law Firm

AZ Lab Life Sciences Law Firm
Call

Building A Bridge Between The U.S. And Chinese Life Science Communities

AZ Lab Life Sciences Law Firm provides strategic legal guidance to facilitate innovative collaboration and drive global growth, with unparalleled experience navigating the complexities of the U.S. and Chinese life sciences sectors.

Contact The Firm

Experienced Legal Support For Regulatory Compliance In The U.S. And China

AZ Lab Life Sciences Law Firm is a boutique law firm that provides U.S.-China life sciences regulatory, compliance, and transactional services. Founded by attorney Anna Zhao, the firm focuses on advising companies and scientists on regulatory strategies and bringing their most promising therapeutics to the market in the U.S. and China. Ms. Zhao helps companies and scientists resolve regulatory issues before the U.S. Food and Drug Administration (FDA) and China’s National Medical Products Administration (NMPA), and she advises on conducting clinical trials, use of foreign clinical trial data, obtaining marketing approvals, regulatory exclusivities, orphan drugs, promotion, post-market compliance, manufacturing and related issues during the life cycle of medical products in the U.S. and China.

Ms. Zhao regularly conducts life sciences due diligence, represents companies in negotiating and drafting a suite of agreements such as life sciences licensing and collaboration agreements, asset purchase agreements, clinical trial agreements, expanded access agreements, manufacturing and quality agreements, pharmacovigilance agreements and other commercial agreements, and has experience in venture capital investment and corporate transactions both in the U.S. and China.

Business & Commercial
Law

Contracts & Commercial
Agreements

Drugs & Medical
Devices

Health Care
Law

Life Sciences
Law

Mergers &
Acquisitions

Anna Zhao

Two Countries. Two Languages.
One Attorney.

Anna Zhao is an experienced bilingual lawyer who has more than ten years’ experience in the U.S. FDA and China NMPA regulatory field and is well acquainted with the Chinese and the U.S. legal, business and cultural environment. Founded by Ms. Zhao, AZ Lab Life Sciences aims to provide a full range of legal solutions to you, from when you have the first breakthrough discovery in the lab to marketing your potential therapeutics in the U.S. and China.

Anna previously practiced in an international law firm in their Beijing and Washington, D.C. offices for a decade and has rich experience working with both established and emerging pharmaceutical companies on the U.S. FDA and China NMPA regulatory, corporate and transactional matters. Drawing from her Chinese background and cross-border regulatory and transactional experience, Anna is well-positioned to advise companies on their clinical trials, manufacturing, drug promotion, marketing, post-marketing compliance, and related corporate and commercial transactions.

Get To Know Attorney Zhao

years of experience

practice areas

continents served

Let’s Get Started – Schedule A Consultation.

Ms. Zhao firmly believes that drug discovery and clinical trials have no borders. Whether you need regulatory support in China or the U.S., or would like to sign the next agreements, AZ Lab Life Sciences is here to help you craft and execute the strategies to bring your most promising therapeutics to benefit the global patients.

The firm aims to build a bridge between the U.S.-China biotech science and business communities. Together, we can work out the differences, facilitate the dialogue between the U.S. and China biotech industries, and achieve the goal of benefiting patients worldwide.

To get started, call 312-219-9542 or contact the office via email.